ClinTex Platform - Managing Clinical Trials with Blockchain
A clinical trial is a medical study performed on different people. An important application of clinical trials is in the study of the effects of new drugs and treatments.
A new medicinal product or device is tested on humans when convincing information about the quality and safety of the product has been collected and approved by the health authorities or the research ethics committee in the country where the research is being conducted.
Pharmaceutical and biotechnology companies conduct clinical trials to test the safety and efficacy of new drugs and treatments to obtain legal approval from relevant bodies such as the FDA, EMA, and others.
The current method of conducting a clinical trialThe initial phase of a clinical trial examines the safety of a drug in the initial phase of the trial. This sometimes takes several months, and usually involves several healthy volunteers who are paid to participate in the study.
These studies are designed to examine the effects of drugs or devices on humans, such as how they are absorbed, metabolized, and excreted. This initial phase of the test also measures the side effects of the drug by increasing its dose. Approximately 70% of the drugs are accepted in this test.
The second phase of a clinical trial is to test the effectiveness of that particular drug or device and can last from several months to several years and involve hundreds of patients. Most studies in the second phase are randomized trials, in which a group of patients take the drug under test and the second group undergoes standard and routine treatment.
The trial is usually conducted in such a way that neither the patient nor the researcher knows which group of patients took the test drug. By doing so, researchers can provide pharmaceutical companies and the FDA with detailed information about the relative safety and effects of the new drug. Almost one-third of experimental drugs successfully pass phase one and phase two.
In the third phase of the clinical trial, the drug is tested in several hundred to several thousand patients. In this phase, too, no one knows which group of patients received the drug.
This phase usually takes place on a large, global scale and can take several years for pharmaceutical companies and the FDA to assess the effectiveness of a drug or device, its benefits, and its adverse reactions. Between 70 and 90% of drugs come out of this phase successfully. When the third phase is completed, a pharmaceutical company can submit a marketing request for the drug to the FDA.
But there is a fourth phase, commonly referred to as post-marketing surveillance, that takes place when the drug is available to consumers. In this phase, pharmaceutical companies pursue several goals:
1-Comparing the drug with other drugs available in the market
2-Evaluation of long-term effectiveness of the drug and its effects on patients' quality of life
3-Diagnosing the cost-effectiveness of drug therapy in comparison with other traditional and new methods of treatment
In the fourth phase, it is possible that a drug or device will be collected from the market or that restrictions will be imposed on it.
ClinTex CTi, a breakthrough in clinical trialsThe ClinTex CTi (Clinical Trials Intelligence) platform is a data collaboration and analysis platform that leverages blockchain technology to provide a decentralized solution for sharing clinical trial data.
ClinTex offers innovative solutions based on blockchain technology to provide self-service analytics to companies in the pharmaceutical industry. The ClinTex platform improves the clinical trial process by providing revolutionary tools to increase the efficiency of operational processes, the quality of clinical data and reviews.
In addition, ClinTex technology enables machine learning and facilitates simple collaboration in clinical trials.
Using Ethereum's smart contracts, the platform creates tools for unifying data sharing among industry players. This solution significantly enhances the quality and improves the operational processes in the conduct of clinical trials by advanced clinical data analysis, predictive data analysis and machine learning.
ClinTex CTi brings significant improvement and much greater efficiency to the operations of pharmaceutical companies and facilitates the commissioning, implementation, monitoring, review and enforcement of clinical trials.
The basis of the ClinTex CTi platform is to create an ecosystem that provides the ability to share all clinical trial data simultaneously and, on the other hand, to create a secure environment for storing and analyzing historical clinical trial data using blockchain.
Through ClinTex CTi, an ecosystem is formed that includes 7 decentralized applications. Together, these applications provide valuable insights into clinical trials by leveraging analytical and predictive tools and machine learning.
ClinTex Target Market The goal of the ClinTex platform is very clear: to make the clinical trial more efficient.
The clinical trial industry is currently valued at about $ 350 billion and includes pharmaceutical companies, clinical research organizations and academic institutions. These companies and organizations are responsible for conducting tests to test the safety and effectiveness of new drugs.
The ClinTex platform accesses and supports multiple sources of clinical trial information. This information includes drug data, patient data, vendor data, and research data collected and made available on the ClinTex platform. The platform accelerates collaboration between industry actors and facilitates predictable analytics and data-driven insights.
ClinTex initially partnered with Intellimed to expand the ClinTex platform into clinical research centers. Adding to the customer base is ClinTex target for mid-2019 (when the corporate introduction of pharmaceutical companies conducting clinical trials begins).
Advantages of blockchain technology for clinical trialsBut why ClinTex has chosen blockchain technology for improvement in clinical trials, here are 7 benefits of blockchain for clinical trials.
Clinical data security: Blockchain runs on a network of different computers, and each blockchain record exists on all network devices. If an attempt is made to modify or delete a particular record, that chain or transaction will immediately be considered as fake data and will not be saved.
Unchangeable transactions: Audits are one of the necessary and control processes for all clinical data. The FDA and other government agencies must be able to verify the quality and validity of the data, and a pharmaceutical company must, in accordance with GCP (Good Clinical Practice), record all changes made to the data, the person who made the changes, and the timing. Ledger is a great tool for keeping these records.
Historical data: In addition to the immutability of the blockchain, the ability to store clinical historical data on the blockchain allows the creation and implementation of machine learning algorithms that have the ability to grow over time and can be a powerful tool for predicting clinical trials. This feature provides new opportunities to increase the effectiveness and quality of clinical research.
Payments: Blockchain technology has the ability to securely execute contracts and make step-by-step payments. For example, a payment such as a designation could be made at a specific time for researchers who have entered and approved their data.
Interoperability: Because blockchain can be integrated seamlessly across multiple data systems and formats, it will be possible to compute and maintain ClinTex criteria across multiple clinical trials. As a result, powerful analyzes and predictions are obtained by modifying the algorithm and creating a learning platform.
Privacy: Privacy is crucial in the field of clinical trials around the world. One of the most basic ideas in blockchain solutions is the ability to verify data in the records, without observing the content of that data. This feature enables individuals and machines to act on clinical data without disclosing the content of the data to them.
Access control: According to FDA rules, access to clinical data must be restricted to licensed individuals, and each person must have their own key to access the data. Blockchain technology offers a complete and perfect solution in this case. The ClinTex platform uses encrypted keys to access records in the blockchain.
CTI TokenClinTex Token will release its unique built-in logo, which will have multiple uses on the CTi platform. With the release of the CTi Infrastructure Token, all platform participants such as pharmaceutical companies, clinical research organizations, researchers, vendors and other third parties can become part of the decentralized clinical trial asset management ecosystem.
Different levels of access to analytics are given to Token holders (based on the amount of their Token inventory). The required inventory for accesses will be announced before the official start.
To access the CTi platform, an authorization is granted when the user purchases the specified amount of Token CTi from the market and enters it in the wallet integrated with the platform. Once a user has been licensed, Tokens must remain in the CTi Walt platform for as long as the license is valid (for example, 1 year) and the user will not be able to sell it.
With the decommissioning of Tokens due to their being stacked by users who want to access the platform, the supply of CTi Tokens will naturally decrease. With the release of 7 CTi ecosystem applications and marketing for it, the demand for platform access licenses is expected to increase steadily and thus the demand for buying and stacking CTi Tokens will be stable. This could lead to an increase in Token prices. A large number of people who have purchased and maintained Tokens to access the platform are expected to renew their licenses by not selling them. This way, this amount of Token is still not available. But if a person is reluctant to extend their access to the CTi platform, under the initial agreement, 25 percent of the burned tokens will be added and the rest will be added to the circulating tokens. This is done automatically through smart contracts. Token CTi has another application. This Token is used to make payments to researchers and third party vendors on the CTi platform.

ClinTex Partners and PartnersThe Enterprise Ethereum Alliance provides the resources needed to support the current and future development of the ClinTex platform and to leverage Ethereum technology to modernize the collaboration of pharmaceutical companies.
Zerafa Advocates is a law firm specializing in providing legal advice to blockchain-related businesses. Their insight into the rules, with ClinTex ensures that they always comply with the rules.
• Applicatur is a blockchain development agency that collaborates with blockchain projects and encourages them to grow in the blockchain ecosystem by analyzing the project and examining the company's business model.
Intellimed is an innovative company in the field of health technology that focuses on simplifying UK National Health Service processes, reducing costs and improving patient healthcare.
• Global Blockchain Consortium, GBC was formed with the aim of promoting blockchain awareness and training in the field of fintech, new technologies and blockchain technology. The mission of the GBC is to partner strategically with organizations and individuals that provide revolutionary solutions in the field of fintech and blockchain.
Chainlink is a blockchain interface that enables smart contracts to access resources outside of the blockchain, such as news feeds, APIs, and traditional payments.
Clintex’s Team
With regards to the team project Clintex, then there is a very strong core team:
Clintex’s RoadmapIn the picture below, the project roadmap gas been described:
The last wordBlockchain technology will revolutionize many industries with its features, one of which is the field of pharmaceuticals, medicine and clinical trials. Blockchain deals with data, and the ability to distribute and change data through blockchain makes this technology unique.
It has also provided a valuable item that affects all aspects of the development of new drugs and therapies.
After a trial and test, the data are used on a large scale to diagnose the safety and effectiveness of the drug, to prevent or limit the marketing of the drug if proven to be harmful.
The decentralized clinical trial ecosystem created and developed by ClinTex improves their ability to collaborate and assist by bringing all stakeholders together and on track. This ecosystem enables pharmaceutical companies to meet the stringent standards that exist in conducting clinical trials.
The ClinTex ecosystem also increases the quality and speed with which new drugs enter the market, ensuring the safety and effectiveness of the treatments needed by patients.
Official resources:ClinTex Website:
https://clintex.io//ClinTex Medium Page:
https://medium.com/@clintexctiClinTex Official Telegram:
https://t.me/ClinTexCTiClinTex Official Twitter:
https://twitter.com/ClinTexCTiAutor:Altcoinstalks Name: rezanahvi
Altcoinstalks URL:
https://www.altcoinstalks.com/index.php?action=profile;area=summary;u=21385